Providing medical and scientific research information in the field of clinical trials. Drugreboot.ai is software service that analyzes a failed trial to discover molecular features associated with drug response. Drugreboot.ai combines the molecular features with the patient's clinical attributes to predict the reasons why the drug failed in the clinical trial and provides additional analysis using disease models identifies strategies for salvaging the therapy. The software provides the user w...